Dow Up0.48% Nasdaq Up0.43%

Alnylam Pharmaceuticals, Inc. (ALNY)

-NasdaqGS
68.05 0.83(1.23%) Aug 19, 4:00PM EDT
Analyst OpinionGet Analyst Opinion for:
Recommendation Summary*
Mean Recommendation (this week):2.2
Mean Recommendation (last week):2.3
Change:-0.1

* (Strong Buy) 1.0 - 5.0 (Sell)

Price Target Summary
Mean Target:100.60
Median Target:101.00
High Target:110.00
Low Target:90.00
No. of Brokers:5

Data provided by Thomson/First Call

Upgrades & Downgrades History
DateResearch FirmActionFromTo
Feb 11, 2013MLV & CoDowngradeBuyHold
Oct 14, 2011Rodman & RenshawInitiated Mkt Outperform
May 6, 2011MLV CapitalInitiated Buy
May 20, 2010ThinkEquityInitiated Buy
Nov 24, 2009Roth CapitalDowngradeBuyHold
Jun 10, 2009Jefferies & CoInitiated Buy
Jun 10, 2009Roth CapitalInitiated Buy
Feb 25, 2009NeedhamUpgradeUnderperformHold
Aug 20, 2008Leerink SwannInitiated Underperform
Mar 3, 2008Needham & CoDowngradeHoldUnderperform

More Upgrades & Downgrades for ALNY

Data provided by Briefing.com - Take a free trial
Complete Live market analysis of the U.S. stock and bond markets, technology stocks, economic releases, earnings reports, and day trading highlights.

Recommendation Trends
Current MonthLast MonthTwo Months AgoThree Months Ago
Strong Buy0111
Buy0555
Hold0222
Underperform0000
Sell0000

Data provided by Thomson/First Call


Currency in USD.